CRWV heads into its August 6 earnings window with short interest still running at an extreme level — but the week's data shows the first meaningful pullback in weeks, even as the stock continues to fall.
The short position is large by any measure, but it just got slightly less crowded. Short interest fell 9% on the week to 23.2% of free float — roughly 89.8 million shares — after peaking above 105 million earlier in the month. That's a notable retreat from the July 7-9 spike, though the one-month picture tells a different story: shorts have added 57% in 30 days, building from the low-60-million-share base that prevailed through most of June. The borrow market is not amplifying the bear case. Cost to borrow is running below 0.5%, barely changed on the week, and availability has loosened to 219% — meaning there are more than two shares available to borrow for every share already borrowed. That's a tight-enough lending pool to mark a genuine shift from the 500–870% availability readings of mid-June, but nowhere near the squeeze conditions the 52-week low of 0.07% availability implies is possible. Options are equally quiet. The put/call ratio sits at 0.81, almost exactly in line with its 20-day average, and a z-score near zero confirms there's no unusual directional pressure building in derivatives. The positioning picture is elevated but not accelerating — and the borrow market suggests the short trade remains cheap and accessible.
The Street is more divided than the consensus "buy" rating implies. Two fresh analyst moves on July 15 cut targets on the name: Mizuho maintained Neutral and dropped its target from $110 to $100, while Macquarie held its Outperform rating but trimmed from $140 to $130. Both moves come as the stock trades at $79.94, down 20% over the past month. Further back in the recent history, Rosenblatt maintains a $250 target and Buy rating, and Cantor Fitzgerald has repeatedly reiterated Overweight at $167 — which illustrates just how wide the range of views is. The mean target across the coverage universe sits at $140, implying roughly 75% upside from current levels, but that gap is difficult to square with a stock that has spent the last month erasing gains. Factor scores add nuance: the EPS surprise rank is high at the 83rd percentile, reflecting a history of beating estimates, but EPS momentum over 30 and 90 days ranks in the bottom quartile — 6th and 24th percentile respectively — suggesting estimates have been moving the wrong way. The short score of 63.8 has edged down from the recent high of 65.9 on July 8, consistent with the mild short covering seen this week.
Founder and CEO Michael Intrator sold approximately $5.4 million worth of stock across multiple transactions on July 7-8, at prices ranging from $83 to $90 — levels the stock has since fallen below. The sales appear to be part of an ongoing programme rather than a discrete directional call: net insider activity over 90 days is actually mildly positive at roughly 420,000 shares, reflecting large initial allocations at IPO. Still, the CEO transacting at prices now above the market is worth noting as context for sentiment. On the institutional side, BlackRock added nearly 10 million shares through June 30, while co-founders Brian Venturo and Brannin McBee have each trimmed their stakes in recent reporting periods.
The earnings history for CRWV carries a sharp warning. The May 7 print saw the stock fall 17% the next day and remain down 17% five days later — a punishing reaction for a growth name with this level of short interest. The June 8 print was benign by comparison, with a 2% drop on the day followed by a 6% recovery over the following week. The bear case is straightforward: customer concentration, heavy capital requirements, and a debt load that constrains flexibility. The bull case rests on GPU utilisation efficiency, NVIDIA partnership depth, and a total addressable market that remains genuinely large. With August 6 now less than four weeks away, how the short base behaves into that date — and whether analysts continue trimming targets as the stock underperforms their models — is the thread most worth pulling.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
